Table 2 Analysis in individual populations
SNP IDCzech RepublicAustriaFinland
MAF casesMAF controlsBest p corrOR (95% CI)MAF casesMAF controlsBest p corrOR (95% CI)MAF casesMAF controlsBest p corrOR (95% CI)
n = 276n = 412n = 222n = 570n = 88n = 246
rs67103410.13090.145611.13 (1.55 to 0.83)0.13060.141210.91 (0.66 to 1.26)0.12070.158510.73 (0.43 to 1.22)
rs124690630.29710.21720.04921.52 (1.19 to 1.95)0.31080.24260.00641.41 (1.11 to 1.79)0.31610.24390.60931.43 (0.98 to 2.10)
rs23004780.30250.22090.02851.53 (1.20 to 1.96)0.32430.24870.00171.45 (1.14 to 1.84)0.32760.24590.36761.49 (1.02 to 2.18)
rs92962490.16490.23060.02521.52 (1.15 to 2.00)0.16440.23780.01161.59 (1.19 to 2.11)0.24140.35160.10811.70 (1.15 to 2.53)
rs39238090.23010.29980.03741.43 (1.12 to 1.84)0.2230.31330.00491.59 (1.23 to 2.05)0.26510.41190.01241.94 (1.32 to 2.87)
rs42360600.20470.26620.19031.41 (1.09 to 1.83)0.19680.28910.00281.66 (1.27 to 2.17)0.26740.39210.04971.77 (1.20 to 2.60)
rs116354240.27720.33500.01351.31 (1.04 to 1.66)0.27930.32290.10141.23 (0.97 to 1.57)0.30460.286611.09 (0.75 to 1.59)
rs37847090.27540.32890.01241.29 (1.02 to 1.63)0.27250.31850.05221.25 (0.98 to 1.59)0.30460.274411.16 (0.79 to 1.69)
rs10267320.27170.33500.00501.35 (1.07 to 1.71)0.27480.3220.05191.25 (0.98 to 1.60)0.30460.276411.15 (0.79 to 1.67)
rs64946960.27170.33500.00501.35 (1.07 to 1.71)0.27480.32290.04161.26 (0.99 to 1.60)0.30460.276411.15 (0.79 to 1.67)
  • MAF, minor allele frequencies in each subsample in patients and healthy individuals; n, number of successfully genotyped individuals by passing quality control criteria; Best p corr, p values corrected for multiple testing according to the full association model in table 1; OR, odds ratio and corresponding 95% confidence intervals (CI); SNP, single nucleotide polymorphism.